Septodont

Septodont and Acteon Group signed an agreement to acquire Inibsa, a Spanish pharmaceutical laboratory specializing in dental products. Septodont will hold 51% and Acteon Group 49%. Announced November 5, 2024.

Septodont and Acteon have signed an agreement to become shareholders of Inibsa, a global pharmaceutical group based in Barcelona, Spain. Septodont will acquire a controlling stake, with Acteon as a non-controlling shareholder. The deal is subject to regulatory approvals.

Septodont, through its subsidiary Sofic, will build a new 6,000 m² dental needle factory on the Causse zone in Aussillon, France, with a total investment of EUR 15 million. The new facility will double the current surface area and increase production capacity by 50%.

Septodont will invest €12 million to build a new 6,000 m² plant for its subsidiary Sofic near Castres-Mazamet airport in the Tarn department. Construction is expected to start in summer 2019, with the building operational by end of 2021.

Septodont built a new production facility near Paris for injectable dental anaesthetic cartridges, investing nearly €26 million. The three-level, 2,700 sqm building has been fully operational since end of 2016.